Protocol Ledger

NCT05554406 · Phase II · RECRUITING

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Interventional Phase II clinical trial protocol NCT05554406 sponsored by National Cancer Institute (NCI) in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-09-25 Enrollment: 335 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05554406
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)335 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05554406
Protocol FieldVerified Registry Value
NCT IdentifierNCT05554406
Consolidated Lead SponsorNational Cancer Institute (NCI)
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment335 participants (ESTIMATED)
Registered Start Date2024-09-25
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI